1. Home
  2. VHI vs MRVI Comparison

VHI vs MRVI Comparison

Compare VHI & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VHI
  • MRVI
  • Stock Information
  • Founded
  • VHI 1932
  • MRVI 2014
  • Country
  • VHI United States
  • MRVI United States
  • Employees
  • VHI N/A
  • MRVI N/A
  • Industry
  • VHI Major Chemicals
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • VHI Industrials
  • MRVI Health Care
  • Exchange
  • VHI Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • VHI 447.6M
  • MRVI 312.4M
  • IPO Year
  • VHI N/A
  • MRVI 2020
  • Fundamental
  • Price
  • VHI $18.10
  • MRVI $2.67
  • Analyst Decision
  • VHI Sell
  • MRVI Hold
  • Analyst Count
  • VHI 1
  • MRVI 10
  • Target Price
  • VHI $12.00
  • MRVI $6.84
  • AVG Volume (30 Days)
  • VHI 25.1K
  • MRVI 1.9M
  • Earning Date
  • VHI 08-07-2025
  • MRVI 08-06-2025
  • Dividend Yield
  • VHI 1.77%
  • MRVI N/A
  • EPS Growth
  • VHI 4465.30
  • MRVI N/A
  • EPS
  • VHI 4.11
  • MRVI N/A
  • Revenue
  • VHI $2,112,800,000.00
  • MRVI $241,856,000.00
  • Revenue This Year
  • VHI $22.20
  • MRVI N/A
  • Revenue Next Year
  • VHI $7.66
  • MRVI $10.62
  • P/E Ratio
  • VHI $4.41
  • MRVI N/A
  • Revenue Growth
  • VHI 7.82
  • MRVI N/A
  • 52 Week Low
  • VHI $14.10
  • MRVI $1.67
  • 52 Week High
  • VHI $41.75
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • VHI 67.06
  • MRVI 67.02
  • Support Level
  • VHI $15.95
  • MRVI $2.32
  • Resistance Level
  • VHI $18.70
  • MRVI $2.72
  • Average True Range (ATR)
  • VHI 0.77
  • MRVI 0.15
  • MACD
  • VHI 0.28
  • MRVI 0.05
  • Stochastic Oscillator
  • VHI 82.56
  • MRVI 92.36

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: